Re: “Genotyping and Molecular Characterization of Fluoroquinolone's Resistance Among Multidrug-Resistant Mycobacterium tuberculosis in Southwest of China” by Hu et al.
Restricted accessLetterFirst published online April, 2022
Re: “Genotyping and Molecular Characterization of Fluoroquinolone's Resistance Among Multidrug-Resistant Mycobacterium tuberculosis in Southwest of China” by Hu et al.
HuY., LiuJ., ShenJ., et al.2021. Genotyping and molecular characterization of fluoroquinolone's resistance among multidrug-resistant Mycobacterium tuberculosis in Southwest of China. Microb. Drug Resist. 27:865–870.
2.
YangC., LuoT., SunG., et al. 2012. Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in China. Clin. Infect. Dis. 55:1179–1187.
3.
BheringM., and KritskiA.2020. Primary and acquired multidrug-resistant tuberculosis: predictive factors for unfavorable treatment outcomes in Rio de Janeiro, 2000–2016. Rev. Panam. Salud. Publica. 44:e178.
4.
Allix-BeguecC., WahlC., HanekomM., et al. 2014 Proposal of a consensus set of hypervariable mycobacterial interspersed repetitive-unit-variable-number tandem-repeat loci for subtyping of Mycobacterium tuberculosis Beijing isolates. J. Clin. Microbiol. 52:164–172.
5.
MokrousovI., VyazovayaA., PasechnikO., et al. 2019. Early ancient sublineages of Mycobacterium tuberculosis Beijing genotype: unexpected clues from phylogenomics of the pathogen and human history. Clin. Microbiol. Infect. 25:1039.e1–1039.e6.
6.
LiY., HuY., MansjoM., et al.2018. The epidemiological significance and temporal stability of mycobacterial interspersed repetitive units-variable number of tandem repeats-based method applied to Mycobacterium tuberculosis in China. Int. J. Environ. Res. Public Health, 15:782.
7.
ZhaoB., LiuC., FanJ., et al. 2021. Transmission of multidrug/rifampicin-resistant, Mycobacterium tuberculosis, in Chongqing, China: A retrospective observational study using whole-genome sequencing. Preprint from Research Square, PPR37, 5273.
